Medicine and Dentistry
Wart Virus
100%
Cost-Effectiveness Analysis
100%
Human Papillomavirus Type 16
100%
AS04
100%
Health Care Cost
80%
Screening
60%
Human Papillomavirus Type 6
40%
Quality Adjusted Life Year
40%
Lifespan
20%
Papillomavirus Infection
20%
Cervical Cancer
20%
Vaccine
20%
Cervical Cancer Screening
20%
Cervical Cancer Prevention
20%
Mass Immunization
20%
Head
20%
Nursing and Health Professions
Vaccination Policy
100%
Vaccine Efficacy
100%
Cost Effectiveness Analysis
100%
AS04
83%
Screening
50%
Uterine Cervix Cancer
50%
Quality Adjusted Life Year
33%
Cancer Screening
16%
Cancer Prevention
16%
Papillomavirus Infection
16%
Incremental Cost-Effectiveness Ratio
16%
Mass Immunization
16%
Pharmacology, Toxicology and Pharmaceutical Science
Human Papillomavirus
100%
Human Papillomavirus Type 16
100%
AS04
100%
Vaccination Policy
100%
Uterine Cervix Cancer
60%
Human Papillomavirus Type 6
40%
Vaccine
20%
Papillomavirus Infection
20%